2014Central Plains Medical JournalRequires access

Effect of valsartan combined with sulodexide on diabetic nephropathy

Yulin Wang, Zijun Yang, Liuwei Wang, Jun-tong Chen, Lin Tang

Open publisher page 0 citations

Abstract

Objective To observe the effect of the combined therapy of valsartan and sulodexide on diabetic nephropathy(DN).Methods Thirty-six patients with DN-Ⅲ stage and thirty-six patients with DN-Ⅳ stage were randomized divided into valsartan group,sulodexide group,valsartan and sulodexide group,each group had 12 patients.The follow-up was 12 weeks.Then the UAER,24 h urinary protein,serum creatinine,blood lipid,plasma albumin were measured.Results After treatment of 12 weeks,the level of UAER of DN-Ⅲ stage and 24 h urinary protein of DN-Ⅳ stage decreased significantly in all the three groups,and no significant difference was observed between valsartan group and sulodexide group(P > 0.05)in the two stages,but significant difference was noted compared with combined therapy group(P < 0.05).Conclusions Valsartan combined with sulodexide can effectively decrease the level of urine protein in patients with DN and the effect is better than single application. Key words: Diabetic nephropathy ;  Sulodexide ;  Valsartan

About this research paper

What this paper is about

Objective To observe the effect of the combined therapy of valsartan and sulodexide on diabetic nephropathy(DN).Methods Thirty-six patients with DN-Ⅲ stage and thirty-six patients with DN-Ⅳ stage were randomized divided into valsartan group,sulodexide group,valsartan and sulodexide group,each group had 12 patients.The follow-up was 12 weeks.Then the UAER,24 h urinary protein,serum creatinine,blood lipid,plasma albumin were measured.Results After treatment of 12 weeks,the level of UAER of DN-Ⅲ stage and 24 h urinary protein of DN-Ⅳ stage decreased significantly in all the three groups,and no significant difference was observed between valsartan group and sulodexide group(P > 0.05)in the two stages,but significant difference was noted compared with combined therapy group(P < 0.05).Conclusions Valsartan combined with sulodexide can effectively decrease the level of urine protein in patients with DN and the effect is better than single application. Key words: Diabetic nephropathy ;  Sulodexide ;  Valsartan

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of the combined therapy of valsartan and sulodexide on diabetic nephropathy(DN).Methods Thirty-six patients with DN-Ⅲ stage and thirty-six patients with DN-Ⅳ stage were randomized divided into valsartan group,sulodexide group,valsartan and sulodexide group,each group had 12 patients.The follow-up was 12 weeks.Then the UAER,24 h urinary protein,serum creatinine,blood lipid,plasma albumin were measured.Results After treatment of 12 weeks,the level of UAER of DN-Ⅲ stage and 24 h urinary protein of DN-Ⅳ stage decreased significantly in all the three groups,and no significant difference was observed between valsartan group and sulodexide group(P > 0.05)in the two stages,but significant difference was noted compared with combined therapy group(P < 0.05).Conclusions Valsartan combined with sulodexide can effectively decrease the level of urine protein in patients with DN and the effect is better than single application. Key words: Diabetic nephropathy ;  Sulodexide ;  Valsartan

Key concepts: Valsartan, Medicine, Diabetic nephropathy, Creatinine, Urology, Internal medicine, Endocrinology, Urinary system

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of valsartan combined with sulodexide on diabetic nephropathy — Research Paper | ScholarLens